Tech Company Financing Transactions
OncoGenex Pharmaceuticals Funding Round
On 7/20/2009, OncoGenex Pharmaceuticals received $9.5 million in financing from private investors.
Transaction Overview
Company Name
Announced On
7/20/2009
Transaction Type
Venture Equity
Amount
$9,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
19820 North Creek Pkwy. 201
Bothell, WA 98011
USA
Bothell, WA 98011
USA
Phone
Website
Email Address
Overview
OncoGenex Pharmaceuticals (NASDAQ: OGXI) is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address unmet needs in the treatment of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Cormack
Chief Financial Officer
John Bencich
Chief Medical Officer
Cindy Jacobs
VP - Marketing
Jaime Welch
Browse more venture capital transactions:
Prev: 7/20/2009: Akiban Technologies venture capital transaction
Next: 7/20/2009: Intent Media venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs